EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Phenotypic variation of FXN compound heterozygotes in a Friedreich ataxia cohort

Megan M Shen, Christian Rummey iD, David R Lynch iD

Annals of Clinical and Translational Neurology · 2024-05 · 11 (5) · 1110-1121

DOI: 10.1002/acn3.52027 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Clinical and Translational Neurology, online erschienen am 23.02.2024. Verfasst von Megan M Shen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neurology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Frataxin, Friedreich Ataxia, Heterozygote, Phenotype. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Friedreich Ataxia Research Alliance.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Most individuals with Friedreich ataxia (FRDA) have homozygous GAA triplet repeat expansions in the FXN gene, correlating with a typical phenotype of ataxia and cardiomyopathy. A minority are compound heterozygotes carrying a GAA expansion on one allele and a mutation on the other. The study aim was to examine phenotypic variation among compound heterozygotes.

Methods

Data on FXN mutations were obtained from the Friedreich Ataxia Clinical Outcome Measures Study (FA‐COMS). We compared clinical features in a single‐site FA‐COMS cohort of 51 compound heterozygous and 358 homozygous patients, including quantitative measures of cardiac, neurologic, and visual disease progression.

Results

Non‐GAA repeat mutations were associated with reduced cardiac disease, and patients with minimal/no function mutations otherwise had a typical FRDA phenotype but with significantly more severe progression. The partial function mutation group was characterized by relative sparing of bulbar and upper limb function, as well as particularly low cardiac involvement. Other clinical features in this group, including optic atrophy and diabetes mellitus, varied widely depending on the specific type of partial function mutation.

Interpretation

These data support that the typical FRDA phenotype is driven by frataxin deficiency, especially severe in compound heterozygotes with minimal/no function mutations, whereas the heterogeneous presentations of those with partial function mutations may indicate other contributing factors to FRDA pathogenesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FrataxinFriedreich AtaxiaHeterozygotePhenotypeAdolescentAdultChildFemaleHumansMaleMiddle AgedYoung AdultCohort StudiesMutationTrinucleotide Repeat Expansion

Substanzen

Frataxin

Autor:innen und Institutionen

  • Division of Neurology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Perelman School of Medicine, University of Pennsylvania., Philadelphia, Pennsylvania, USA.
  • Clinical Data Science GmbH, Basel, Switzerland.

ORCID-Profile: Christian Rummey, David R Lynch

Förderung

  • Friedreich Ataxia Research Alliance

Zitieren

APA

Shen, M. M., Rummey, C., & Lynch, D. R. (2024). Phenotypic variation of FXN compound heterozygotes in a Friedreich ataxia cohort. Annals of Clinical and Translational Neurology, 11(5), 1110-1121. https://doi.org/10.1002/acn3.52027

Vancouver

Shen MM, Rummey C, Lynch DR. Phenotypic variation of FXN compound heterozygotes in a Friedreich ataxia cohort. Annals of Clinical and Translational Neurology. 2024;11(5):1110-1121. doi:10.1002/acn3.52027

BibTeX
@article{Shen2024,
  author = {Shen, Megan M and Rummey, Christian and Lynch, David R},
  title = {Phenotypic variation of FXN compound heterozygotes in a Friedreich ataxia cohort},
  journal = {Annals of Clinical and Translational Neurology},
  year = {2024},
  volume = {11},
  number = {5},
  pages = {1110--1121},
  doi = {10.1002/acn3.52027}
}
Kostenlos starten →